Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
WADA does not state why it has banned BPC-157, but presumably there are concerns about the lack of research into its safety and the (also unresearched) possibility that it does indeed enhance athletic performance
Some protocols may adjust frequency depending on individual response and goals
Typical Protocol: Commonly cited protocols use 1.5-1.6 mg subcutaneously two to three times per week (mirroring the Zadaxin regimen used in hepatitis trials), often run in 4 to 16 week cycles for general wellness use, with the original clinical trials using 1.6 mg twice weekly for 6 to 12 months
Reported cellular endpoints include endothelial and keratinocyte migration, collagen deposition, integrin-linked kinase and Akt activation, and HIF-1 alpha interaction in migration assays
Before taking this medicine, let your doctor know any other medicines you are taking
BPC-157 upregulates growth hormone receptors on tendon fibroblasts while TB-500 utilizes those receptors for enhanced tissue repair
US$ 29.73
US$ 28.89
US$ 21.42
